Study finds that push to prescribe fewer antibiotics is working Updated on: September 29,2025 Study finds that push to prescribe fewer antibiotics is working Updated on:September 29,2025
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients Updated on: September 29,2025 New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients Updated on:September 29,2025
Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer Updated on: September 29,2025 Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer Updated on:September 29,2025
Popular diabetes drug shows anti-aging effects among patients with type 2 diabetes Updated on: September 29,2025 Popular diabetes drug shows anti-aging effects among patients with type 2 diabetes Updated on:September 29,2025
Who updates list of essential medicines to include GLP-1s Updated on: September 29,2025 Who updates list of essential medicines to include GLP-1s Updated on:September 29,2025
New medication lowers hard-to-control high blood pressure in people with chronic kidney disease Updated on: September 29,2025 New medication lowers hard-to-control high blood pressure in people with chronic kidney disease Updated on:September 29,2025
LSD may ease anxiety symptoms for months, study finds Updated on: September 29,2025 LSD may ease anxiety symptoms for months, study finds Updated on:September 29,2025
DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC Updated on: September 29,2025 DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC Updated on:September 29,2025
Media visibility and costs of new medicines under examination—what does the media highlight? Updated on: September 28,2025 Media visibility and costs of new medicines under examination—what does the media highlight? Updated on:September 28,2025
Weekly Update of Drug News-25/9/2025 On September 8, 2025, Pfizer and BioNTech announced positive results from an ongoing Phase 3 clinical trial evaluating the safety...... Updated on: September 25,2025 Weekly Update of Drug News-25/9/2025 On September 8, 2025, Pfizer and BioNTech announced positive results from an ongoing Phase 3 clinical trial evaluating the safety...... Updated on:September 25,2025